Sam Herron

ID: 1b83b8f7-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

EMA’s CHMP Recommends Approval of Six New Biosimilars

Big Molecule Watch · December 26, 2024

FDA approves CAR-T Cell Therapy for Refractory B-cell Precursor Acute Lymphoblastic Leukemia

Big Molecule Watch · November 19, 2024

Amgen Files BPCIA Complaint Against Fresenius Kabi Regarding Denosumab

Big Molecule Watch · October 14, 2024

The Centers for Medicare & Medicaid Services Announces Lower Prices for First Ten Drugs Selected for Medicare Price Negotiation

Big Molecule Watch · September 9, 2024

FDA Issues Draft Guidance on Postapproval Manufacturing Changes to Biosimilar Products

Big Molecule Watch · August 2, 2024